SEC Form 4 · accession 0001179110-16-020719
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Funck
Officer — Vice President, Controller
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 29, 2016 | F | 2,838 | $39.52 | D | 86,352 | D | |
| Common shares without par value | Feb 29, 2016 | S | 933 | $39.305 | D | 85,419 | D | |
| Common shares without par value | Feb 29, 2016 | S | 100 | $39.304 | D | 85,319 | D | |
| Common shares without par value | Feb 29, 2016 | S | 300 | $39.3023 | D | 85,019 | D | |
| Common shares without par valueF1 | holding | — | — | — | 16,242 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By Daughter | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By Daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 29, 2016.
- F2The reporting person disclaims beneficial ownership of all securities held by his daughter.
Remarks
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).